Regression of Sebaceous Carcinoma of the Eyelid after a Small Incisional Biopsy: Report of Two Cases.
Exenteration
Eyelid
Orbit
Ptosis
Sebaceous carcinoma
Small incisional biopsy
Spontaneous regression
Journal
Ocular oncology and pathology
ISSN: 2296-4681
Titre abrégé: Ocul Oncol Pathol
Pays: Switzerland
ID NLM: 101656139
Informations de publication
Date de publication:
Jun 2019
Jun 2019
Historique:
received:
02
05
2018
revised:
07
06
2018
entrez:
2
8
2019
pubmed:
2
8
2019
medline:
2
8
2019
Statut:
ppublish
Résumé
To report 2 cases of regression of sebaceous carcinoma of the eyelid after a small incisional biopsy. Clinical, imaging, and histopathological findings are presented, with a literature review on regressing ocular tumors. Our first patient was a 79-year-old man who presented with a 10-month history of progressive left upper eyelid ptosis caused by an eyelid tumor with orbital involvement and confirmed on magnetic resonance imaging. Our second patient was a 70-year-old woman who presented with ptosis with a left upper eyelid mass. Both patients underwent a small incisional biopsy of their lesion. The histopathological diagnoses in both cases were consistent with sebaceous carcinoma. Both patients refused exenteration. Follow-up clinical examination and imaging disclosed total regression of the ptosis and of the neoplasm with no sign of recurrence in both patients over a 4-year period for Case 1 and a 7-year period for Case 2. Regression following incisional biopsy of basal cell, squamous cell, and Merkel cell carcinoma, including of the eyelid, is well documented. To the best of our knowledge, our 2 cases of sebaceous carcinoma are the first to be reported with total involution clinically and on imaging of the tumor following partial incisional biopsy.
Identifiants
pubmed: 31367586
doi: 10.1159/000490706
pii: oop-0005-0252
pmc: PMC6615332
doi:
Types de publication
Case Reports
Langues
eng
Pagination
252-257Déclaration de conflit d'intérêts
The authors have no financial conflict of interest to disclose. All of the authors have seen and given their approval for the submission of this paper. They warrant that this article is the authors' original work, has not received prior publication, and is not under consideration for publication elsewhere.
Références
Biomed Pharmacother. 2000 Aug;54(7):410-4
pubmed: 10989981
J Cutan Pathol. 2003 Feb;30(2):139-46
pubmed: 12641794
Surv Ophthalmol. 2005 Mar-Apr;50(2):103-22
pubmed: 15749305
Ophthalmology. 2008 Jan;115(1):195-201
pubmed: 17531320
J Cutan Pathol. 2008 Jul;35(7):641-6
pubmed: 18201230
Mod Pathol. 2010 Apr;23(4):567-73
pubmed: 20118912
Ophthalmic Plast Reconstr Surg. 2010 May-Jun;26(3):208-10
pubmed: 20489549
Am J Ophthalmol. 2014 Jan;157(1):186-208.e2
pubmed: 24112633
Ophthalmology. 2014 Apr;121(4):964-71
pubmed: 24290802
Can J Ophthalmol. 2014 Aug;49(4):326-32
pubmed: 25103648
Ocul Oncol Pathol. 2015 Dec;2(2):71-5
pubmed: 27171611
Br J Dermatol. 1977 Jul;97(1):1-10
pubmed: 329852
Br J Ophthalmol. 1982 Nov;66(11):685-90
pubmed: 7126513
Acta Derm Venereol. 1976;56(5):361-5
pubmed: 78620
Br J Dermatol. 1994 Jan;130(1):1-8
pubmed: 7905746
Natl Cancer Inst Monogr. 1976 Nov;44:67-76
pubmed: 799762